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We studied the effect of high-fat diet on the expression and activation of the three caveolins in rat
skeletal muscle and their association with the insulin signalling cascade. Initial response was char-
acterized by increased signalling through Cav-1 and Cav-3 phosphorylation, suggesting that both
participate in an initial acute response to the calorie surplus. Afterwards, Cav-1 signalling was
slightly reduced, whereas Cav-3 remained active. Late chronic phase signalling through both pro-
teins was impaired inducing a prediabetic state. Summarizing, caveolins seem to mediate a time-
dependent regulation of insulin cascade in response to high-fat diet in muscle.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Obesity is commonly attributed to an imbalance between food
intake and energy expenditure resulting in the storing of energy
excess as fat, primarily in adipose tissue and secondly in skeletal
muscle, liver, pancreas and brain [1]. Different genes have been re-
lated to obesity development, such as the 3 major isoforms of cave-
olins, Cav-1, Cav-2 and Cav-3 (18–24 kDa), which are the main
structural components of caveolae [2]. Cav-1 is most abundantly
expressed in terminally differentiated cells, such as adipocytes,
ﬁbroblasts, epithelial and endothelial cells. Cav-2 is coexpressed
with Cav-1, forming hetero-oligomers that require Cav-1 for prop-
er membrane localization. Finally, Cav-3, whose function is similar
to Cav-1, is considered as the muscle-speciﬁc member of the cave-
olin family, although it has also been found in astrocytes and chon-
drocytes [3,4]. Interestingly, Cav-1 is also expressed in skeletal
muscle, where it interacts with Cav-3 in a speciﬁc manner [5].
Caveolae have been related to endocytosis of differentmolecules
or particles, such as cholesterol and fatty acids [6], but they act also
as scaffolding structures for the organization of a variety of signal
transduction proteins [7]. Thus, there is considerable evidence ofchemical Societies. Published by E
ood Sciences, Physiology and
8 Pamplona, Spain. Fax: +34caveolin involvement in the modulation of insulin signalling and
therefore in the regulation of the intermediary metabolism, which
becomes altered in obesity, and associated with metabolic disor-
ders such as insulin resistance and type 2 diabetes [7]. For instance,
Cav-3 deﬁcient mice develop late-onset obesity accompanied by
insulin resistance in key peripheral tissues and abnormal lipid
metabolism [8,9].
Therefore, it is clear that caveolins may play an important reg-
ulatory role in muscle insulin signalling. A better understanding of
the insulin signalling deregulation that accompanies obesity is a
prerequisite to improve therapeutic treatments. Thus, in this work
we sought to investigate the effect of high-fat diet feeding in cave-
olin expression and activation in skeletal muscle and its relation
with the deregulation of insulin signalling and the onset of a pre-
diabetic state.
2. Materials and methods
2.1. Animals, diets and experimental design
MaleWistar rats (250–300 g), purchased from the Applied Phar-
macobiology Center (CIFA, University of Navarra, Spain), were
housed under controlled conditions of temperature (22 ± 2 C), rel-
ative humidity (55 ± 10%) and light cycle (8 a.m. to 8 p.m). Fifty-six
animals were assigned to two different dietary groups for 72 days.
The control group (n = 28) had ad libitum access to standardlsevier B.V. All rights reserved.
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the second group (n = 28) was fed a fat-rich cafeteria diet [10]. Rats
were sacriﬁced by decapitation, after overnight fasting, in four mo-
ments during the experimental period: 4, 12, 35 and 72 days. Each
group was made up of eight control (C) and eight high-fat fed ani-
mals (HF), excepting the groups of day 72 (n = 4, each). After the
sacriﬁce, trunk blood was collected and gastrocnemius skeletal
muscle immediately isolated, frozen in liquid nitrogen, and stored
at 80 C. All the procedures were performed according to national
guidelines and under care of the Animal Care and Use Committee
at the University of Navarra.
2.2. Analysis of blood samples
Serum glucose was analyzed using a Cobas Mira autoanalyzer
(Roche Diagnostics, Basel, Switzerland) by enzymatic routine pro-
cedures. Serum insulin levels were measured by ELISA (Mercodia
AB, Uppsala, Sweden). HOMA index was calculated as fasting insu-
lin (lU/mL)  fasting glucose (mmol/L)/22.5.
2.3. Reverse transcription (RT)-PCR
Total RNAwas extracted from frozen skeletal muscle with Trizol
(Invitrogen, Carlsbad, CA, USA), puriﬁed by DNase treatment (DNA-
freeTM kit, Applied Biosystems, Austin, TX, USA) and used as a tem-
plate to generate ﬁrst strand cDNA using M-MLV reverse transcrip-
tase (Invitrogen, Carlsbad, CA, USA). Quantitative real-time PCR
was performed as described by the provider (Applied Biosystems,
Austin, TX, USA) using an ABI-PRISM 7300 HT Sequence Detection
System and Taqman probes for rat Cav-1, Cav-2, Cav-3, GLUT-4, IR,
IRS-1 and IRS-2. GAPDH was used as internal control for efﬁciency
of RT-PCR and subsequent normalization. The results were calcu-
lated by the 2DDCt method [11].
2.4. Western blot analyses
For Western blot analysis, skeletal muscle samples were
homogenized with lysis buffer. Ten to ﬁfteen micrograms protein
were electrophoretically separated and incubated with speciﬁc pri-
mary antibodies at the suitable dilution and following a standard
protocol [12]. The blots were stripped by immersion in Red-Blot
Plus solution 10X for 10 min at room temperature (Millipore, Bille-
rica, MA, USA) and reprobed with different antibodies, using the
same procedure as described above. Cav-1 (1/50 000), Cav-2 (1/
20 000) and Cav-3 (1/10 000) antibodies were from Santa Cruz Bio-
technology Inc., CA, USA; Insulin Receptor (1/10 000) and Phospho-
tyrosine (1/10 000), from Cell Signalling Technology. The
secondary antibodies were Anti-Mouse (1/10 000), from Amer-
sham Biosciences-GE Healthcare, WI, USA, Anti-Rabbit (1/10 000),
from Sigma Aldrich, St. Louis, MO, USA, and Anti-Goat (1/10 000),
from Santa Cruz Biotechnology Inc.
2.5. Inmunoprecipitation
For immunoprecipitation, samples containing 500 lg of total
protein were incubated with antibodies against Cav-1 (1/100 v/
w), Cav-3 (1/100 v/w) and IR (1/50 v/v) following the supplier’s
protocols (Santa Cruz Biotechnology Inc. and Cell Signalling Tech-
nology), before being analyzed by Western blot with the corre-
sponding antibodies, as described above, and quantiﬁed by
densitometry.
2.6. Data analysis
The results were expressed as the mean ± S.E.M. Data were
compared using Mann–Whitney U test, while correlation analyseswere performed using Spearman’s rho. All analyses were per-
formed using SPSS version 15.0 for Windows.3. Results
3.1. Body weight and blood determinations
Rats consuming the high-fat diet (HF) gained signiﬁcantly more
weight (P < 0.05) than those receiving the control diet, increasing
body fat percentage and decreasing relative muscle weight with
respect to total body weight since day 12 (Fig. 1). They also devel-
oped hyperglycemia, hiperinsulinemia and insulin resistance at the
end of the experimental period (Fig. 1).
3.2. mRNA and protein levels of caveolins
Cav-3 mRNA, measured by RT-PCR, resulted signiﬁcantly in-
creased in HF-fed rats from day 12 as compared to the control
group (Fig. 2). Cav-1 and Cav-2 show a similar expression pattern
than Cav-3, although the differences were not signiﬁcant (Fig. 2).
Caveolin protein contents in skeletal muscle, quantiﬁed by
Western blot analysis, were not affected by the diet (Fig. 3A). How-
ever, Cav-1 and Cav-3 show a positive and Cav-2 an inverse corre-
lation to body weight (Fig. 3B).
3.3. Protein phosphorylation of Cav-1, Cav-3 and IR
Phosphorylation levels of IR, Cav-1 and Cav-3 were increased in
HF-fed rats at day 4, as a sort of initial response (Fig. 4), more evi-
dent for IR (P < 0.05) and Cav-3 (P = 0.053). However, from day 12
ahead, IR phosphorylation level in HF animals was the same as in
control fed rats (Fig. 4), indicating that there is no response of IR
to the increased insulin circulating level.
3.4. mRNA expression of insulin pathway proteins
Neither IR nor GLUT4 mRNAs were modiﬁed by the diet (Fig. 5).
IRS-1 increased its expression in HF animals at day 4, as an early
response to the diet, but from day 12 ahead, it gradually decreased
(P < 0.05 at day 72). On the other hand, IRS-2 showed an inverse
expression pattern to IRS-1, being inhibited up to day 35 but signif-
icantly increased at day 72 (Fig. 5).
4. Discussion
After 10 weeks of high-fat cafeteria diet, rats developed a predi-
abetic state characterized by hyperinsulinemia and insulin resis-
tance, as previously reported [13]. Skeletal muscle is the major
organ responsible for glucose uptake under insulin-stimulated con-
ditions [14], and is generally considered the most important site for
insulin resistance [15]. An impairment of the initial steps of insulin
signalling transduction pathways could contribute to the defect in
insulin-stimulated glucose uptake in skeletal muscle, thus resulting
in insulin resistance. In fact, two mechanisms have been described
in relation to lipid-induced muscle insulin resistance: acute free
fatty acid elevation, and prolonged muscle lipid accumulation [16].
In this study, increased insulin resistance in animals fed a fat-
rich diet is evidenced by reduced insulin receptor (IR) phosphory-
lation since day 12 and IRS-1 mRNA at day 72, conﬁrming data
from other groups [17]. Cav-1 is also downregulated since day
12, suggesting that this protein may be involved in the malfunction
of the classical insulin pathway that could result in insulin resis-
tance [18].
It is known that caveolin subtypes 1 and 3 play an important
role in maintaining insulin signalling and cellular energy metabo-
Fig. 2. Effect of high-fat diet in caveolin mRNA levels (mean ± S.E.M. of the ratio between each caveolin and GAPDH expression, and referred to control group gene expression
(C = 100)). C vs. HF, **P < 0.01; *P < 0.05.
Fig. 1. Effect of high-fat diet in body weight and serum measurements (mean ± S.E.M.). C vs. HF, ***P < 0.001; **P < 0.01; *P < 0.05; T < 0.10.
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resistance to diet-induced obesity, dyslipidemia and important fat
tissue pathology [19,20], which has been attributed to defectiveinsulin signalling [20]. In adipocytes, a dramatic reduction in IR
phosphorylation has been described [20], which has been ex-
plained by the reduction of the IR protein itself with normal mRNA
Fig. 3. (A) Effect of high-fat diet in caveolin protein levels in skeletal muscle (mean ± S.E.M. of the ratio between each caveolin and actin and are referred to control group
gene expression (C = 100)). C vs. HF, T < 0.10. (B) Association analysis between muscle caveolin protein levels and ﬁnal body weight (R = Spearman’s rho): C (black line and
spots) and HF (dotted line and x marks). Protein levels are expressed as the normalized ratio between caveolin and actin signals for each individual sample.
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skeletal muscle, remained unchanged.
Cav-3 knockout mice show loss of caveolae in skeletal muscle
plasma membrane and abnormalities in the organization of the
T-tubule system [21], developing adiposity, dyslipidemia and
hyperglycemia [9]. In skeletal muscle, the protein expression of
IR and other molecules involved in insulin signalling are unaltered,
whereas phosphorylation of IR, IRS or Akt/PKB are all attenuated
and insulin-stimulated glucose uptake is decreased [8].
Our results indicate that HF diet seems to induce, in muscle
insulin signalling, a time dependent response with three different
stages. In the initial response against the excess of nutrient input
(day 4), IR, Cav-1 and Cav-3 are highly phosphorylated and IRS-1
mRNA upregulated. Cav-1 is also slightly upregulated, as reported
by other authors using similar diets [22]. This early response of
Cav-1 could be related to the high amount of cholesterol and the
overload of fatty acids in the diet [22], but also to the release of
the inﬂammatory cytokine TNF-alpha [23]. Therefore, we suggest
that, in this prompt response, insulin-related pathways might be
activated by a coordinated mechanism mediated by both caveolins
and IR, in an attempt to effectively ﬁght against the excess of die-
tary nutrients in order to maintain glucose balance.
After 12 days, the initial response change towards an adaptation
to the new metabolic state, probably mediated by damage in the
main insulin pathway and the overwhelming of the cell with more
fat and glucose that it can oxidize. Subsequently, at day 35, a de-layed response characterized by the establishment of an obese
metabolism was observed [24], with the animals showing hyper-
glycemia, hyperinsulinemia and insulin resistance. In accordance
to this, Cav-1 and IR are no longer activated. Hyperglycemia could
also be contributing to Cav-1 downregulation at this stage, as other
authors have shown in Schwann cells [25]. Cav-1 expression pat-
tern is similar to that observed in adipose tissue in previous stud-
ies, while Cav-2 behaves in the opposite way [26,27], suggesting
that they are inversely regulated. In adipocytes Cav-1 co-localizes
with IR and positively regulates the activation of IR upon insulin
stimulation [28], but the role of Cav-1 in muscle insulin signalling
has received little attention, probably because Cav-3 is the muscle-
speciﬁc isoform. Our results suggest that insulin signalling could
be downregulated due to a decrease in Cav-1 and IR phosphoryla-
tion, in accordance to other authors that have reported reduced
muscle insulin-stimulated glucose uptake after siRNA downregula-
tion of Cav-1 [5].
However, we also ﬁnd that Cav-3 expression and phosphoryla-
tion are still upregulated at day 35, suggesting that Cav-3 may be
actually playing a role in the regulation of insulin signalling in
this stage. It has been described that, although IR phosphorylation
in skeletal muscle is not affected by Cav-3 downregulation, Cav-3
is essential in the maintenance of interactions with the cell cyto-
skeleton through other caveolae molecules, such as ﬂotillin-1
[29]. Thus, insulin stimulation in skeletal muscle cells results in
the translocation to the plasma membrane of internal domains
Fig. 4. Effect of high-fat diet in Cav-1, Cav-3 and IR phosphorylation in skeletal muscle (mean ± S.E.M. of the ratio between each phosphoprotein and total caveolin and are
referred to control group gene expression (C = 100)). C vs. HF, **P < 0.01; T < 0.10.
Fig. 5. Effect of high-fat diet in mRNA levels of IR, IRS1, IRS2 and GLUT4 in skeletal muscle (mean ± S.E.M. of the ratio between each gene and GAPDH expression and are
referred to control group gene expression (C = 100)). C vs. HF, *P < 0.05; T < 0.10.
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cess that is facilitated by Cav-3–ﬂotillin-1 interaction [29]. In this
context, in adipocytes, a dominant Cav-3 mutant inhibits insulin-stimulated GLUT4 translocation and activation of TC10 (a Rho
family GTPase), in a manner independent from PI-3 kinase path-
way [30].
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high-fat diet exposure decreases Cav-1 phosphorylation and IR
activation, resulting in a reduction of GLUT-4 translocation by sim-
ilar mechanisms as in adipocytes as suggested by the decrease in
IRS-1 mRNA levels. However, cafeteria diet also induces Cav-3 acti-
vation, which through cytoskeletal modiﬁcations could regulate
spatial and temporal compartmentalization of GLUT4 vesicles, in
an alternative attempt to maintain glucose homeostasis.
Finally, in a late chronic phase (day 72), Cav-3 is also dephos-
phorylated indicating that both signalling pathways are impaired.
This will cause strong insulin resistance, marked hyperglycemia
and the establishment of a prediabetic state. This hypothesis is
supported by other authors, who observed reduced levels of Cav-
3 in cardiomyoblasts in insulin resistant state [31]. Interestingly
IRS-2 mRNA levels are signiﬁcantly higher at this stage, but how
this increase might be linked to the metabolic situation is some-
thing that remains to be tested.
In summary, we suggest a coordinated mechanism involving
caveolins and IR in muscle cells, in which feeding a high-fat cafete-
ria diet appears to induce a three stage time-dependent insulin re-
sponse: initial, delayed and chronic. The initial response would be
characterized by an intense signalling through Cav-1 and Cav-3
phosphorylation. Afterwards, the intensity of signalling would be
reduced since Cav-1 is inhibited but Cav-3 remains active. Finally,
in the late phase, signalling through both proteins would be im-
paired inducing a prediabetic state.
Acknowledgements
The skilful technical assistance of Adela Bezunartea is gratefully
acknowledged. A. Gómez was recipient of a fellowship from ‘‘Aso-
ciación de Amigos de la Universidad de Navarra”, Spain. This study
was supported by Plan de Investigación de la Universidad de Nava-
rra (PIUNA) and Línea Especial from University of Navarra (LE/97),
Spain.
References
[1] Martinez, J.A., Parra, M.D., Santos, J.L., Moreno-Aliaga, M.J., Marti, A. and
Martinez-Gonzalez, M.A. (2008) Genotype-dependent response to energy-
restricted diets in obese subjects: towards personalized nutrition. Asia Paciﬁc
J. Clin. Nutr. 17 (Suppl. 1), 119–122.
[2] Williams, T.M. and Lisanti, M.P. (2004) The caveolin genes: from cell biology to
medicine. Ann. Med. 36, 584–595.
[3] Schwab, W., Galbiati, F., Volonte, D., Hempel, U., Wenzel, K.W., Funk, R.H.,
Lisanti, M.P. and Kasper, M. (1999) Characterisation of caveolins from
cartilage: expression of caveolin-1, -2 and -3 in chondrocytes and in alginate
cell culture of the rat tibia. Histochem. Cell Biol. 112, 41–49.
[4] Shin, T., Kim, H., Jin, J.K., Moon, C., Ahn, M., Tanuma, N. and Matsumoto, Y.
(2005) Expression of caveolin-1, -2, and -3 in the spinal cords of Lewis rats
with experimental autoimmune encephalomyelitis. J. Neuroimmunol. 165,
11–20.
[5] Oh, Y.S., Cho, K.A., Ryu, S.J., Khil, L.Y., Ju, H.S., Yoon, J.W. and Park, S.C. (2006)
Regulation of insulin response in skeletal muscle cell by caveolin status. J. Cell
Biochem. 99, 747–758.
[6] Lajoie, P. and Nabi, I.R. (2007) Regulation of raft-dependent endocytosis. J. Cell.
Mol. Med. 11, 644–653.
[7] Schwencke, C., Braun-Dullaeus, R.C., Wunderlich, C. and Strasser, R.H. (2006)
Caveolae and caveolin in transmembrane signalling: Implications for human
disease. Cardiovasc. Res. 70, 42–49.
[8] Oshikawa, J., Otsu, K., Toya, Y., Tsunematsu, T., Hankins, R., Kawabe, J.,
Minamisawa, S., Umemura, S., Hagiwara, Y. and Ishikawa, Y. (2004) Insulin
resistance in skeletal muscles of caveolin-3-null mice. Proc. Natl. Acad. Sci.
USA 101, 12670–12675.
[9] Capozza, F., Combs, T.P., Cohen, A.W., Cho, Y.R., Park, S.Y., Schubert, W.,
Williams, T.M., Brasaemle, D.L., Jelicks, L.A., Scherer, P.E., Kim, J.K. and Lisanti,
M.P. (2005) Caveolin-3 knockout mice show increased adiposity and wholebody insulin resistance, with ligand-induced insulin receptor instability in
skeletal muscle. Am. J. Physiol. Cell Physiol. 288, C1317–C1331.
[10] López, I.P., Marti, A., Milagro, F.I., Zulet, M.A., Moreno-Aliaga, M.J., Martinez,
J.A. and De Miguel, C. (2003) DNA microarray analysis of genes differentially
expressed in diet-induced (cafeteria) obese rats. Obes. Res. 11, 188–194.
[11] Crujeiras, A.B., Parra, D., Milagro, F.I., Goyenechea, E., Larrarte, E., Margareto, J.
and Martinez, J.A. (2008) Differential expression of oxidative stress and
inﬂammation related genes in peripheral blood mononuclear cells in response
to a low-calorie diet: a nutrigenomics study. Omics 12, 251–261.
[12] González-Muniesa, P., Milagro, F.I., Campión, J. and Martínez, J.A. (2006)
Reduction in energy efﬁciency induced by expression of the uncoupling
protein, UCP1, in mouse liver mitochondria. Int. J. Mol. Med. 17, 591–597.
[13] Campión, J., Milagro, F.I., Fernández, D. and Martínez, J.A. (2006) Differential
gene expression and adiposity reduction induced by ascorbic acid
supplementation in a cafeteria model of obesity. J. Physiol. Biochem. 62, 71–80.
[14] Baron, A.D., Brechtel-Hook, G., Johnson, A., Cronin, J., Leaming, R. and
Steinberg, H.O. (1996) Effect of perfusion rate on the time course of insulin-
mediated skeletal muscle glucose uptake. Am. J. Physiol. 271, E1067–E1072.
[15] Hegarty, B.D., Furler, S.M., Ye, J., Cooney, G.J. and Kraegen, E.W. (2003) The role
of intramuscular lipid in insulin resistance. Acta Physiol. Scand. 178, 373–383.
[16] Ye, J.M., Doyle, P.J., Iglesias, M.A., Watson, D.G., Cooney, G.J. and Kraegen, E.W.
(2001) Peroxisome proliferator-activated receptor (PPAR)-alpha activation
lowers muscle lipids and improves insulin sensitivity in high fat-fed rats:
comparison with PPAR-gamma activation. Diabetes 50, 411–417.
[17] Sugita, H., Fujimoto, M., Yasukawa, T., Shimizu, N., Sugita, M., Yasuhara, S.,
Martyn, J.A. and Kaneki, M. (2005) Inducible nitric-oxide synthase and NO
donor induce insulin receptor substrate-1 degradation in skeletal muscle cells.
J. Biol. Chem. 280, 14203–14211.
[18] Nandi, A., Kitamura, Y., Kahn, C.R. and Accili, D. (2004) Mouse models of
insulin resistance. Physiol. Rev. 84, 623–647.
[19] Razani, B., Combs, T.P., Wang, X.B., Frank, P.G., Park, D.S., Russell, R.G., Li, M.,
Tang, B., Jelicks, L.A., Scherer, P.E. and Lisanti, M.P. (2002) Caveolin-1-deﬁcient
mice are lean, resistant to diet-induced obesity, and showhypertriglyceridemia
with adipocyte abnormalities. J. Biol. Chem. 277, 8635–8647.
[20] Cohen, A.W., Razani, B., Wang, X.B., Combs, T.P., Williams, T.M., Scherer, P.E.
and Lisanti, M.P. (2003) Caveolin-1-deﬁcient mice show insulin resistance and
defective insulin receptor protein expression in adipose tissue. Am. J. Physiol.
Cell Physiol. 285, C222–C235.
[21] Galbiati, F., Engelman, J.A., Volonte, D., Zhang, X.L., Minetti, C., Li, M., Hou Jr.,
H., Kneitz, B., Edelmann, W. and Lisanti, M.P. (2001) Caveolin-3 null mice show
a loss of caveolae, changes in the microdomain distribution of the dystrophin-
glycoprotein complex, and t-tubule abnormalities. J. Biol. Chem. 276, 21425–
21433.
[22] Munoz, P., Mora, S., Sevilla, L., Kaliman, P., Tomas, E., Guma, A., Testar, X.,
Palacin, M. and Zorzano, A. (1996) Expression and insulin-regulated
distribution of caveolin in skeletal muscle. Caveolin does not colocalize with
GLUT4 in intracellular membranes. J. Biol. Chem. 271, 8133–8139.
[23] Wang, L., Lim, E.J., Toborek, M. and Hennig, B. (2008) The role of fatty acids and
caveolin-1 in tumor necrosis factor alpha-induced endothelial cell activation.
Metabolism 57, 1328–1339.
[24] Margareto, J., Gomez-Ambrosi, J., Marti, A. and Martinez, J.A. (2001) Time-
dependent effects of a high-energy-yielding diet on the regulation of speciﬁc
white adipose tissue genes. Biochem. Biophys. Res. Commun. 283, 6–11.
[25] Tan, W., Rouen, S., Barkus, K.M., Dremina, Y.S., Hui, D., Christianson, J.A.,
Wright, D.E., Yoon, S.O. and Dobrowsky, R.T. (2003) Nerve growth factor blocks
the glucose-induced down-regulation of caveolin-1 expression in Schwann
cells via p75 neurotrophin receptor signalling. J. Biol. Chem. 278, 23151–
23162.
[26] López, I.P., Milagro, F.I., Martí, A., Moreno-Aliaga, M.J., Martínez, J.A. and De
Miguel, C. (2004) Gene expression changes in rat white adipose tissue after a
high-fat diet determined by differential display. Biochem. Biophys. Res.
Commun. 318, 234–239.
[27] López, I.P., Milagro, F.I., Martí, A., Moreno-Aliaga, M.J., Martínez, J.A. and De
Miguel, C. (2005) High-fat feeding period affects gene expression in rat white
adipose tissue. Mol. Cell. Biochem. 275, 109–115.
[28] Yamamoto, M., Toya, Y., Schwencke, C., Lisanti, M.P., Myers Jr., M.G. and
Ishikawa, Y. (1998) Caveolin is an activator of insulin receptor signalling. J.
Biol. Chem. 273, 26962–26968.
[29] Fecchi, K., Volonte, D., Hezel, M.P., Schmeck, K. and Galbiati, F. (2006) Spatial
and temporal regulation of GLUT4 translocation by ﬂotillin-1 and caveolin-3
in skeletal muscle cells. FASEB J. 20, 705–707.
[30] Watson, R.T., Shigematsu, S., Chiang, S.H., Mora, S., Kanzaki, M., Macara, I.G.,
Saltiel, A.R. and Pessin, J.E. (2001) Lipid raft microdomain
compartmentalization of TC10 is required for insulin signalling and GLUT4
translocation. J. Cell Biol. 154, 829–840.
[31] Ha, H. and Pak, Y. (2005) Modulation of the caveolin-3 and Akt status in
caveolae by insulin resistance in H9c2 cardiomyoblasts. Exp. Mol. Med. 37,
169–178.
